1. Chantelau E: Insulin responsiveness of tumor growth. Editorial. Arch Physiol Biochem. 2009, 115: 47-48.
2. EMEA: Lantus-procedural steps taken and scientific information after the authorisation. Changes made after 1 September 2003. CHMP Commission Decision, May 5,2010, No. R/0062. (see assessment history, to be accessed via Lantus:EPAR).
3. Müssig K, Staiger H, Kantartzis K, Fritsche A, Kanz L, Häring HU: Type-2 diabetes mellitus and risk of malignancy: is there a strategy to identify subphenotype of patients with increased susceptibility to endogenous and exogenous hyperinsulinism?. Diabetic Med. 2010, 10.1111/j.1464-5491.2010.03132x.